Tag:
Amsterdam Molecular Therapeutics
Latest Headlines
Latest Headlines
AMT's Glybera, delivered through virus, faces Euro reg delay
European regulators have slammed on the breaks and delayed an approval decision for Amsterdam Molecular Therapeutics ' Glybera, a gene therapy delivered by an altered virus for patients with a rare
Forbion raises $240M investment fund
European investment firm Forbion Capital Partners has announced the closing of a €190 million ($240m) life sciences investment fund. The VC--which has offices in the Netherlands and
AMT looks for funding while it waits for EMA approval
Dutch biotech Amsterdam Molecular Therapeutics' stock took a hit yesterday after the company revealed it would need additional funding to bridge the gap between Q2 2011--when the company will run out
Promising data reported for cholesterol-lowering gene therapy
Amsterdam Molecular Therapeutics has reported positive preclinical data from a study using an AAV gene therapy product to lower cholesterol. The data show that a single dose of the therapy carrying a
